S428-0633 Screening compound: 3-(oxan-4-yl)-5-(pyrrolidin-2-yl)-1,2,4-oxadiazole

S428-0633 Screening compound: 3-(oxan-4-yl)-5-(pyrrolidin-2-yl)-1,2,4-oxadiazole
S428-0633 Screening compound: 3-(oxan-4-yl)-5-(pyrrolidin-2-yl)-1,2,4-oxadiazole alternative view

Chemical Structure Depiction of ChemDiv screening compound S428-0633
3-(oxan-4-yl)-5-(pyrrolidin-2-yl)-1,2,4-oxadiazole

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S428-0633

Molecular Formula

C11H17N3O2 (C11 H17 N3 O2)

Compound Name

3-(oxan-4-yl)-5-(pyrrolidin-2-yl)-1,2,4-oxadiazole

IUPAC name

3-(oxan-4-yl)-5-(pyrrolidin-2-yl)-124-oxadiazole

SMILES

C(C1)CNC1c1nc(C2CCOCC2)no1

InChI

InChI=1S/C11H17N3O2/c1-2-9(12-5-1)11-13-10(14-16-11)8-3-6-15-7-4-8/h8-9,12H,1-7H2/t9-/m0/s1

InChI Key

POSKYPCTXNWJIA-VIFPVBQESA-N

MDL Number (MFCD)

MFCD21218123

Chemical and Physical Properties

Saltdata

HCl

Molecular Weight

223.27

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

2.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

-0.029

Distribution Coefficient, logD

-2.593

Water Solubility, LogSw

-0.50

Polar Surface Area

52.415

Acid Dissociation Constant (pKa)

24.55

Base Dissociation Constant (pKb)

9.96

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

81.82

S428-0633 in Drug Discovery

Included in Screening Libraries

3D-Fragment Library (4274 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

CNS MPO Library (28609 compounds)

Ligand-Gated Ion Channels Library (3887 compounds)

Protein-Protein Interaction Library (218420 compounds)

Soluble Diversity Library (15920 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Fragments
  • Cyclic compounds
Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Nervous system
  • Nervous system
  • Eye
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • Epigenetic
Targets:
  • Ion Channels

References: we are preparing a list of scientific research reports with S428-0633 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S428-0633?
Check Price and Availability of S428-0633, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S428-0633 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S428-0633
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S428-0633
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S428-0633 available by request